US · Healthcare
Drug Manufacturers - Specialty & Generic
General Cannabis Corp (CANN) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
The price-to-earnings (P/E) ratio for General Cannabis Corp (CANN) is 18.00 (data as of 2026-03-23).
Dividend yield is not available in the current snapshot for General Cannabis Corp (CANN). Check the MyAverix Finance app for the latest dividend data.
General Cannabis Corp (CANN) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
CANN is listed on US.
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.